MSTX Insider Trading Activity and SEC Form 4 Filings
MSTX insider trading summary
No open-market insider purchases or sales of Mast Therapeutics, Inc. (MSTX) have been reported on SEC Form 4 in the past 12 months.
Latest MSTX insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Mar 27, 2015 | Brandi Roberts | Chief Financial Officer & SVP | Buy | $9K (18,000 @ $0.50) |
| Mar 26, 2015 | Brandi Roberts | Chief Financial Officer & SVP | Buy | $10K (20,000 @ $0.50) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.